A norepinephrine analogue with anticancer activity
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Product Type

Research Area

m-Iodobenzylguanidine (hemisulfate)

Item No. 19998

Technical Information
Formal Name
N-[(3-iodophenyl)methyl]-guanidine, hemisulfate
CAS Number
87862-25-7
Synonyms
  • meta-Iodobenzylguanidine
  • MIBG
Molecular Formula
C8H10IN3 • 1/2H2SO4
Formula Weight
Purity
≥98%
A crystalline solid
DMSO: 2 mg/mlDMSO:PBS (pH 7.2) (1:4): 0.2 mg/ml
λmax
231 nm
SMILES
IC1=CC=CC(CNC(N)=N)=C1.O=S(O)(O)=O
InChi Code
InChI=1S/2C8H10IN3.H2O4S/c2*9-7-3-1-2-6(4-7)5-12-8(10)11;1-5(2,3)4/h2*1-4H,5H2,(H4,10,11,12);(H2,1,2,3,4)
InChi Key
XNACDNPGABUBFR-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    m-Iodobenzylguanidine (MIBG) is an analogue of norepinephrine with anticancer activity.1 It inhibits cell growth in a panel of human and mouse leukemia, fibrosarcoma, melanoma, and neuroblastoma cell lines when used at a concentration of 20 µg/ml and reduces clonogenic survival of L1210 leukemia cells in a concentration-dependent manner. MIBG increases survival in N1E155 and L1210 mouse xenograft models when administered at doses of 40 and 20 mg/kg, respectively. It selectively accumulates in chromaffin tissues and tumors and formulations containing radiolabeled forms of MIBG have been used as imaging agents in the diagnosis and treatment of neuroendocrine tumors.2 MIBG also inhibits ADP-ribose linkage to membrane proteins in turkey erythrocyte membranes.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Smets, L.A., Bout, B., and Wisse, J. Cytotoxic and antitumor effects of the norepinephrine analogue meta-iodo-benzylguanidine (MIBG). Cancer Chemother. Pharmacol. 21(1), 9-13 (1988).

    2. Loesberg, C., van Rooij, H., and Smets, L.A. Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation). Biochim. Biophys. Acta 1037(1), 92-99 (1990).